GE HealthCare (Nasdaq: GEHC), which spun off of General Electric (NYSE: GE) last year, is making more investments in at-home care. On Monday, the company announced a partnership with Biofourmis, a home-based care enabler. The partnership aims to enhance care continuity in the post-acute setting with a focus on lowering the cost of care. GE […]
Biofourmis
As health care providers look to shift more care into the home, Biofourmis is cementing its spot as a home-based care enabler for its partners. Biofourmis was founded in Singapore back in 2015. The company’s U.S. offices are headquartered out of Boston. One of the key segments of Biofourmis’ business is centered around managing post-acute […]
The past few years have been a time of transformation for the hospital-at-home model. As it cements its popularity, new players have begun to rise with it. While hospital at home has long been embraced across the globe — in Australia, Canada and across Europe, for example — the model popped up in the U.S. […]
In the view of most health care stakeholders, the hospital-at-home model is here to stay. Still, there are many hurdles that could still prevent widespread adoption. One of these challenges is clinician comfort with the model, according to Ross Armstrong, chief commercial officer at Biofourmis. “‘Am I going to put my license at risk, if […]
The Centers for Medicare & Medicaid Services (CMS) gave health systems and providers the ability to take hospital at home as a concept and run with it during the public health emergency (PHE). Those providers did so, and now they’re wondering what comes next. With regulatory uncertainty moving forward, the hospital-at-home momentum has been put […]
Just four months after raising $300 million – and reaching unicorn status in the process – Biofourmis has secured another $20 million in funding. In total, the company has amassed a $320 million Series D. Intel Capital, the strategic investment arm of chipmaker Intel Corporation, joined the round. In addition to Intel Capital’s involvement, this […]
For startups, reaching unicorn status — a valuation at over $1 billion — is a major milestone. And with its latest funding round, Biofourmis just surpassed getting there. The company announced Tuesday that it has raised $300 million in Series D. The news runs counter to CB Insights’ recent findings that health tech funding, mega-round […]
The hospital-at-home concept was pioneered over two decades ago at Johns Hopkins. It became in vogue during the earlier parts of the COVID-19 crisis. Now, it feels like just any other part of the at-home care ecosystem. That means there are a lot more home-based care players by nature, including tech-enabled companies like Biofourmis and […]
Subscribe
Receive industry updates and breaking news from HHCN